Skip to Content

A33 (Cefuroxime 250 mg)

Pill imprint A33 has been identified as Cefuroxime axetil 250 mg.

Cefuroxime is used in the treatment of bacterial infection; urinary tract infection; bladder infection; bronchitis; skin or soft tissue infection (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cefuroxime axetil 250 mg A33  Front
Cefuroxime axetil 250 mg A33  Back
Cefuroxime axetil 250 mg A33
Discount Card Promo
Cefuroxime axetil
250 mg
16.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Aurobindo Pharma Limited
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydrogenated cottonseed oil
microcrystalline cellulose
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
65862-0699 Aurobindo Pharma Limited
16714-0400 NorthStar Rx LLC
21695-0370 Rebel Distributors Corp (repackager)
53002-0275 Pharmedix (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.